Aerie Pharmaceuticals, Inc.announced that it has initiated the dosing in a phase II study on netarsudil ophthalmic solution in Japan for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
a manufacturer of pharmaceutical products
Industry PharmaceuticalsOther